Delayed multiple sclerosis diagnosis underscores need for urgent research and awareness boost, report find

FHS
May 30, 2024
2:06 am

A new report from MS Australia reveals that the average time to diagnose multiple sclerosis is nearly four years, highlighting the urgent need for increased research investment and enhanced awareness.

Q&A: Lonza CGT president Daniel Palmacci talks manufacturing amid lower sales outlook

In the past few weeks, Lonza has announced several new facility builds, from its partnership with Vertex Pharmaceuticals on a new cell and gene therapy

September 15, 2023

Hormone therapy for transmasculine individuals may be safer than previously thought

A common concern about gender-affirming hormone therapy for transmasculine people is the risk of red blood cell volume changes and erythrocytosis, a high concentration of

November 27, 2023

Gympass Secures $85M for Corporate Wellness Platform at $2.4B Valuation

What You Should Know: – Gympass, a New York City-based corporate wellness platform raises $85M in a Series F funding round led by EQT Growth, with

August 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.